INTELLIPHARMACEUTICS INTL IN's ticker is IPCI and the CUSIP is 458173101. A total of 20 filers reported holding INTELLIPHARMACEUTICS INTL IN in Q2 2017. The put-call ratio across all filers is 3.75 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $0 | -100.0% | 12 | -99.8% | 0.00% | – |
| Q4 2017 | $5,000 | – | 6,812 | +56666.7% | 0.00% | – |
| Q3 2017 | $0 | -100.0% | 12 | -100.0% | 0.00% | – |
| Q2 2017 | $326,000 | -57.3% | 156,166 | -48.9% | 0.00% | -100.0% |
| Q1 2017 | $763,000 | +63.7% | 305,807 | +86.2% | 0.00% | – |
| Q4 2016 | $466,000 | +124.0% | 164,266 | +65.5% | 0.00% | – |
| Q3 2016 | $208,000 | +13.7% | 99,239 | -16.5% | 0.00% | – |
| Q2 2016 | $183,000 | -32.5% | 118,839 | -10.6% | 0.00% | – |
| Q1 2016 | $271,000 | +14.3% | 132,927 | +12.8% | 0.00% | – |
| Q4 2015 | $237,000 | +11.3% | 117,827 | +0.1% | 0.00% | – |
| Q3 2015 | $213,000 | -38.4% | 117,727 | 0.0% | 0.00% | – |
| Q2 2015 | $346,000 | -33.2% | 117,727 | -36.6% | 0.00% | – |
| Q1 2015 | $518,000 | +16.1% | 185,676 | -6.1% | 0.00% | – |
| Q4 2014 | $446,000 | -23.0% | 197,676 | +2.6% | 0.00% | – |
| Q3 2014 | $579,000 | -24.5% | 192,676 | -4.4% | 0.00% | -100.0% |
| Q2 2014 | $767,000 | +7.7% | 201,476 | +24.4% | 0.00% | 0.0% |
| Q1 2014 | $712,000 | -16.9% | 162,016 | -30.0% | 0.00% | 0.0% |
| Q4 2013 | $857,000 | +36.5% | 231,366 | -27.9% | 0.00% | – |
| Q3 2013 | $628,000 | – | 320,691 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|